-
Product Insights
Overactive Bladder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder – Drugs In Development, 2022, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape. Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary loss of urine (incontinence). Symptoms include feel a sudden urge to urinate that's difficult to control, experience urge...
-
Product Insights
Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscarinic Acetylcholine Receptor M2 (CHRM2) is expressed in various regions of the brain including the cerebellum, cerebral cortex, hippocampus, medulla, striatum, thalamus, lungs, and prostate. An increase in M2 receptors has been associated with depression. The CHRM2 pipeline market research report provides comprehensive information on the CHRM2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...
-
Product Insights
Muscarinic Acetylcholine Receptor M4 (CHRM4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscarinic Acetylcholine Receptor M4 (CHRM4) mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides, and modulation of potassium channels through the action of G proteins. The CHRM4 pipeline market research report provides comprehensive information on the CHRM4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research, and development history as well...
-
Product Insights
Axillary Hyperhidrosis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Axillary Hyperhidrosis Global Clinical Trials Review, H1, 2017" provides an overview of Axillary Hyperhidrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Axillary Hyperhidrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...